JP2009505726A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009505726A5 JP2009505726A5 JP2008527962A JP2008527962A JP2009505726A5 JP 2009505726 A5 JP2009505726 A5 JP 2009505726A5 JP 2008527962 A JP2008527962 A JP 2008527962A JP 2008527962 A JP2008527962 A JP 2008527962A JP 2009505726 A5 JP2009505726 A5 JP 2009505726A5
- Authority
- JP
- Japan
- Prior art keywords
- polymer
- group
- integer
- polymer according
- phosphorylcholine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920000642 polymer Polymers 0.000 claims 16
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 6
- -1 amino, vinyl Chemical group 0.000 claims 4
- 125000000524 functional group Chemical group 0.000 claims 4
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 claims 4
- 229950004354 phosphorylcholine Drugs 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 125000004043 oxo group Chemical group O=* 0.000 claims 3
- CGTADGCBEXYWNE-JUKNQOCSSA-N zotarolimus Chemical group N1([C@H]2CC[C@@H](C[C@@H](C)[C@H]3OC(=O)[C@@H]4CCCCN4C(=O)C(=O)[C@@]4(O)[C@H](C)CC[C@H](O4)C[C@@H](/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C3)OC)C[C@H]2OC)C=NN=N1 CGTADGCBEXYWNE-JUKNQOCSSA-N 0.000 claims 3
- 229950009819 zotarolimus Drugs 0.000 claims 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims 2
- 102000000536 PPAR gamma Human genes 0.000 claims 2
- 108010016731 PPAR gamma Proteins 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 230000001028 anti-proliverative effect Effects 0.000 claims 2
- 239000002246 antineoplastic agent Substances 0.000 claims 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 229940127089 cytotoxic agent Drugs 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 229920000728 polyester Polymers 0.000 claims 2
- 230000002792 vascular Effects 0.000 claims 2
- 229940122361 Bisphosphonate Drugs 0.000 claims 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims 1
- 101800003838 Epidermal growth factor Proteins 0.000 claims 1
- YACHGFWEQXFSBS-UHFFFAOYSA-N Leptomycin B Natural products OC(=O)C=C(C)CC(C)C(O)C(C)C(=O)C(C)C=C(C)C=CCC(C)C=C(CC)C=CC1OC(=O)C=CC1C YACHGFWEQXFSBS-UHFFFAOYSA-N 0.000 claims 1
- 108010006519 Molecular Chaperones Proteins 0.000 claims 1
- 229940079156 Proteasome inhibitor Drugs 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000000692 anti-sense effect Effects 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 230000000975 bioactive effect Effects 0.000 claims 1
- 229920000249 biocompatible polymer Polymers 0.000 claims 1
- 229920002988 biodegradable polymer Polymers 0.000 claims 1
- 239000004621 biodegradable polymer Substances 0.000 claims 1
- 150000004663 bisphosphonates Chemical class 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 claims 1
- 229940116977 epidermal growth factor Drugs 0.000 claims 1
- 229940011871 estrogen Drugs 0.000 claims 1
- 239000000262 estrogen Substances 0.000 claims 1
- 210000003709 heart valve Anatomy 0.000 claims 1
- 150000002596 lactones Chemical group 0.000 claims 1
- YACHGFWEQXFSBS-XYERBDPFSA-N leptomycin B Chemical compound OC(=O)/C=C(C)/C[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)/C=C(\C)/C=C/C[C@@H](C)/C=C(/CC)\C=C\[C@@H]1OC(=O)C=C[C@@H]1C YACHGFWEQXFSBS-XYERBDPFSA-N 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 239000000178 monomer Substances 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 1
- 239000002243 precursor Substances 0.000 claims 1
- 239000003207 proteasome inhibitor Substances 0.000 claims 1
- 208000037803 restenosis Diseases 0.000 claims 1
- 238000007142 ring opening reaction Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 claims 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71199105P | 2005-08-25 | 2005-08-25 | |
| PCT/US2006/031130 WO2007024492A2 (en) | 2005-08-25 | 2006-08-09 | Medical devices and coatings therefore comprising biodegradable polymers with enhanced functionality |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009505726A JP2009505726A (ja) | 2009-02-12 |
| JP2009505726A5 true JP2009505726A5 (https=) | 2009-09-24 |
Family
ID=37772133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008527962A Pending JP2009505726A (ja) | 2005-08-25 | 2006-08-09 | 生分解性ポリマーを含むことにより向上した官能性を有する医療機器及びコーティング |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8871238B2 (https=) |
| EP (1) | EP1940481B1 (https=) |
| JP (1) | JP2009505726A (https=) |
| WO (1) | WO2007024492A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060198867A1 (en) * | 1997-09-25 | 2006-09-07 | Abbott Laboratories, Inc. | Compositions and methods of administering rapamycin analogs using medical devices for long-term efficacy |
| GB0329654D0 (en) | 2003-12-23 | 2004-01-28 | Smith & Nephew | Tunable segmented polyacetal |
| EP2142353A1 (en) | 2007-04-18 | 2010-01-13 | Smith & Nephew PLC | Expansion moulding of shape memory polymers |
| WO2008130954A2 (en) | 2007-04-19 | 2008-10-30 | Smith & Nephew, Inc. | Graft fixation |
| JP5520814B2 (ja) | 2007-04-19 | 2014-06-11 | スミス アンド ネフュー インコーポレーテッド | マルチモーダル形状記憶ポリマー |
| US8852620B2 (en) | 2007-07-20 | 2014-10-07 | Medtronic Vascular, Inc. | Medical devices comprising polymeric drug delivery systems with drug solubility gradients |
| US8182829B2 (en) | 2007-07-27 | 2012-05-22 | Abbott Cardiovascular Systems Inc. | Drug eluting implantable medical device with hemocompatible and/or prohealing topcoat |
| WO2009064806A1 (en) * | 2007-11-12 | 2009-05-22 | Endologix, Inc. | Method and agent for in-situ stabilization of vascular tissue |
| US8147744B2 (en) * | 2009-04-10 | 2012-04-03 | Abbott Cardiovascular Systems Inc. | Method of making a stent formed from crosslinked bioabsorbable polymer |
| US8709465B2 (en) * | 2009-04-13 | 2014-04-29 | Medtronic Vascular, Inc. | Diazeniumdiolated phosphorylcholine polymers for nitric oxide release |
| US20110182964A1 (en) * | 2010-01-22 | 2011-07-28 | Medtronic, Inc. | Vascular Stent Which Elutes Amino Acid-Methyl-Ester Derivatives for the Treatment of Vulnerable Plaque and Vascular Disease |
| JP6163929B2 (ja) * | 2013-07-17 | 2017-07-19 | 日油株式会社 | ホスホリルコリン基含有重合体及びその製造方法 |
| CN106232106B (zh) | 2014-04-18 | 2020-08-11 | 奥本大学 | 用于诱导先天性和适应性免疫力的颗粒状疫苗制剂 |
| US10293044B2 (en) | 2014-04-18 | 2019-05-21 | Auburn University | Particulate formulations for improving feed conversion rate in a subject |
| US10583199B2 (en) | 2016-04-26 | 2020-03-10 | Northwestern University | Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030129215A1 (en) | 1998-09-24 | 2003-07-10 | T-Ram, Inc. | Medical devices containing rapamycin analogs |
| JP3716146B2 (ja) * | 1998-12-15 | 2005-11-16 | 武田薬品工業株式会社 | ポリマーの製造方法 |
| JP2002356542A (ja) * | 2001-05-31 | 2002-12-13 | Canon Inc | ポリヒドロキシアルカノエートを含むカード |
| WO2002098926A2 (en) * | 2001-06-04 | 2002-12-12 | Universite De Liege | Process for depositing strong adherend polymer coating onto an electrically conductive surface |
| SE0202619D0 (sv) * | 2002-09-05 | 2002-09-05 | Fredrik Nederberg | New Polymers and Applications |
| US20050208093A1 (en) * | 2004-03-22 | 2005-09-22 | Thierry Glauser | Phosphoryl choline coating compositions |
| JP4548728B2 (ja) * | 2004-06-11 | 2010-09-22 | キヤノン株式会社 | ビニル基、エステル基、カルボキシル基並びにスルホン酸基を有するポリヒドロキシアルカノエート並びにその製造方法 |
-
2006
- 2006-08-09 EP EP06789654.8A patent/EP1940481B1/en not_active Not-in-force
- 2006-08-09 WO PCT/US2006/031130 patent/WO2007024492A2/en not_active Ceased
- 2006-08-09 JP JP2008527962A patent/JP2009505726A/ja active Pending
- 2006-08-09 US US12/064,105 patent/US8871238B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009505726A5 (https=) | ||
| JP2009506869A5 (https=) | ||
| JP2009505727A5 (https=) | ||
| JP5258300B2 (ja) | フッ化モノマーおよび炭化水素モノマーのポリマー | |
| RU2543330C2 (ru) | Баллонный катетер, покрытый антирестенозным активным ингредиентом и молекулярный диспергирующий агент, способствующий переносу | |
| US8986724B2 (en) | Nitric oxide generating medical devices | |
| JP5264925B2 (ja) | 医療装置のための抗菌コーティングならびにその製造方法および使用方法 | |
| US9598532B2 (en) | Terpolymers as pressure-sensitive adhesives | |
| JP5581202B2 (ja) | ジヒドロキシベンゾエートポリマーおよびその使用 | |
| JP2011514231A5 (https=) | ||
| US7442721B2 (en) | Durable biocompatible controlled drug release polymeric coatings for medical devices | |
| JP5153340B2 (ja) | 薬剤放出制御組成物および薬剤放出性医療器具 | |
| US9127124B2 (en) | Linear polyesteramides from aminophenolic esters | |
| JP2010516432A5 (https=) | ||
| JP5264501B2 (ja) | 室温硬化性ポリマー | |
| JP2004536799A (ja) | コドラッグを含有する持続的放出用ドラッグデリバリーシステム | |
| JP2009530039A (ja) | 医療デバイスを介した高親油性薬剤の送達 | |
| JP2009530031A (ja) | 医療デバイスを介した高親油性薬剤の送達 | |
| JP2009528431A (ja) | 抗菌剤放出ポリマー | |
| CN102027024A (zh) | 释放一氧化氮的聚合物组合物 | |
| WO2015175665A1 (en) | Bioadhesive compounds and methods of synthesis and use | |
| US20110250255A1 (en) | Drug coated stent with endosome-disrupting conjugate | |
| WO2020087896A1 (zh) | 一种具有抗菌活性的医用可降解聚氨酯及其用途 | |
| CN101049518A (zh) | 血管支架的表面改性涂层及其制备方法 | |
| US20090269390A1 (en) | Medical devices, polymers, compositions, and methods for delivering a haloacetate |